A Worldwide Bibliometric Analysis of Tetrandrine Research in Recent Two Decades

Background: Tetrandrine has been the focus of many studies in recent years. Currently, no bibliometric study in this field has been published. This study presents a bibliometric analysis of the articles on tetrandrine research from the WOS core database during the recent two decades. Methods: Documents were retrieved for further bibliometric analysis based on the search terms: [TI = (Tetrandrine OR Sinomeninea OR Hanfangchin A) AND PY = (2000–2021)]. We used Microsoft Excel to conduct the frequency analysis, VOSviewer for data visualization, and RStudio for citation metrics and analysis. The standard bibliometric indicators such as the temporal trends and geographical distribution of publications and citations, prolific authors and co-authorship, keywords citation burst, preferred journals, top-cited articles, and important institutions were applied in this study. Results: 490 documents were retrieved from WOS core database, the retrieved document type consists of 8 categories: 425 articles, 42 meeting abstracts, 8 reviews, 7 corrections, 3 editorial material, 2 proceedings paper, 1 letter, 1 retraction. Corrections and Retractions was excluded from this investigation, the left 482 document were included for furter bibliometric analysis. Conclusion: Based on our findings, there was a continuous growth of publications on tetrandrine research for 22 years since 2000. China was the largest contributor to tetrandrine research, followed by the United States. The most influential author was Cheng Y (Natl Taiwan Univ Hosp). Acta Pharmacol Sin remained the main publication related to tetrandrine research. Chinese Academy of Sciences, is expected to be a good collaborating center in tetrandrine research. The use of tetrandrine in cancer treatment, could be the promising research subject areas to follow.

[1]  Guangrui Huang,et al.  Tetrandrine Ameliorates Rheumatoid Arthritis in Mice by Alleviating Neutrophil Activities , 2022, Evidence-based complementary and alternative medicine : eCAM.

[2]  Shunfei Zhu,et al.  Mechanism of Tetrandrine Against Endometrial Cancer Based on Network Pharmacology , 2021, Drug design, development and therapy.

[3]  Lingling Zhang,et al.  Comparison of different chitosan lipid nanoparticles for improved ophthalmic tetrandrine delivery: formulation, characterization, pharmacokinetic and molecular dynamics simulation. , 2020, Journal of pharmaceutical sciences.

[4]  Yukun Zhang,et al.  History of uses, phytochemistry, pharmacological activities, quality control and toxicity of the root of Stephania tetrandra S. Moore: A review. , 2020, Journal of ethnopharmacology.

[5]  Shao Liu,et al.  A critical review: traditional uses, phytochemistry, pharmacology and toxicology of Stephania tetrandra S. Moore (Fen Fang Ji) , 2020, Phytochemistry Reviews.

[6]  Dongwei Zhang,et al.  Radix Stephaniae Tetrandrine: An emerging role for management of breast cancer. , 2020, Current pharmaceutical design.

[7]  D. Xiao,et al.  Inhibition of laryngeal cancer stem cells by tetrandrine. , 2019, Anti-cancer drugs.

[8]  W. Guo,et al.  Self-Nanoemulsifying Drug Delivery System of Tetrandrine for Improved Bioavailability: Physicochemical Characterization and Pharmacokinetic Study , 2018, BioMed research international.

[9]  Yuan-Lu Cui,et al.  Tetrandrine suppresses articular inflammatory response by inhibiting pro‐inflammatory factors via NF‐κB inactivation , 2016, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[10]  S. Koul,et al.  Abstract 3516: Tetrandrine promotes pancreatic cancer cell apoptosisin vitroand tumor regressionin vivo , 2016 .

[11]  Wei Liu,et al.  Tetrandrine reverses epithelial-mesenchymal transition in bladder cancer by downregulating Gli-1. , 2016, International journal of oncology.

[12]  Q. Lv,et al.  Tetrandrine inhibits migration and invasion of rheumatoid arthritis fibroblast-like synoviocytes through down-regulating the expressions of Rac1, Cdc42, and RhoA GTPases and activation of the PI3K/Akt and JNK signaling pathways. , 2015, Chinese journal of natural medicines.

[13]  Jie Shen,et al.  Simultaneous Determination of Fangchinoline and Tetrandrine in Qi-Fang-Xi-Bi-Granules by RP-HPLC. , 2015, Journal of chromatographic science.

[14]  Chunrong Yu,et al.  Synergistic antitumour activity of sorafenib in combination with tetrandrine is mediated by reactive oxygen species (ROS)/Akt signaling , 2013, British Journal of Cancer.

[15]  T. He,et al.  Tetrandrine Suppresses Cancer Angiogenesis and Metastasis in 4T1 Tumor Bearing Mice , 2013, Evidence-based complementary and alternative medicine : eCAM.

[16]  Baoan Chen,et al.  Research Advances on the Pharmacological Effects of Tetrandrine , 2011 .

[17]  Ke Gong,et al.  Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma , 2011, International journal of cancer.

[18]  T. He,et al.  Tetrandrine Inhibits Wnt/β-Catenin Signaling and Suppresses Tumor Growth of Human Colorectal Cancer , 2011, Molecular Pharmacology.

[19]  Yun Chen,et al.  The Potential of Tetrandrine against Gliomas. , 2010, Anti-cancer agents in medicinal chemistry.

[20]  Guanhua Du,et al.  [Pharmacokinetics of fangchinoline and tetrandrine in rats]. , 2009, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[21]  Daijie Wang,et al.  Ionic liquid-based ultrasound-assisted extraction of fangchinoline and tetrandrine from Stephaniae tetrandrae. , 2009, Journal of separation science.

[22]  W. Fan,et al.  In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel. , 2005, Anticancer research.

[23]  L. Fu,et al.  Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance , 2004, Cancer Chemotherapy and Pharmacology.

[24]  C. Iadecola,et al.  Herbal alkaloid tetrandrine: fron an ion channel blocker to inhibitor of tumor proliferation. , 2004, Trends in pharmacological sciences.

[25]  H. W. Altland,et al.  Structural requirements for tumor-inhibitory activity among benzylisoquinoline alkaloids and related synthetic compounds. , 1973, Journal of medicinal chemistry.

[26]  A. L. Chen,et al.  THE ALKALOIDS OF HAN-FANG-CHI , 1935 .

[27]  Zhao Qing-hua Determination of Tetrandrine and Fangchinoline in Shiwei Fengxiao Capsules by HPLC , 2013 .

[28]  L. Fu,et al.  The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells. , 2002, European journal of cancer.